Schnetzler Gabriel, Bremgartner Markus F, Grossmann Straessle Regina, Spirk David, Tay Fabian, Troxler Saxer Rahel, Traber Martin
F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Bexa Medical Services, Kirchberg, Switzerland.
Front Pharmacol. 2019 Feb 27;10:164. doi: 10.3389/fphar.2019.00164. eCollection 2019.
In Switzerland, Pharmaceutical Medicine has existed as one of 46 physician specialties accredited by the Federal Office of Public Health for more than 20 years. As a medical-scientific discipline, our goal is to enable best possible therapeutic coverage for the benefit of patients and society through a medical need-based development and optimal use of medicinal products. The role of the specialist in Pharmaceutical Medicine is to closely collaborate with various stakeholders of the healthcare system in the context of the discovery, research, development and approval of new medicinal products, as well as safe and effective use of new and established medicinal products in daily clinical practice. The post-graduate training consists of 2 years of patient-related clinical work, followed by 3 years of vocational training at certified training centers in Pharmaceutical Medicine. This also includes completion of an academic post-graduate diploma in Pharmaceutical Medicine (30 ECTS) according to the IFAPP/PharmaTrain syllabus and a 1 day board exam. As part of an ongoing revision of the training curriculum, we are developing a Swiss Catalog of Core Competencies in Pharmaceutical Medicine (SC-PM), based on the IFAPP competency framework for drug development specialists in industry. In this article we discuss how we adapt the scope of the IFAPP competency framework to better reflect such roles in academic institutions or regulatory bodies in Switzerland.
在瑞士，药物医学作为联邦公共卫生办公室认可的46种医师专业之一已存在20多年。作为一门医学科学学科，我们的目标是通过基于医疗需求的药品研发和优化使用，为患者和社会提供尽可能最佳的治疗覆盖。药物医学专家的作用是在新药品的发现、研究、开发和审批过程中，以及在日常临床实践中安全有效地使用新的和已有的药品时，与医疗保健系统的各利益相关方密切合作。研究生培训包括2年与患者相关的临床工作，随后在药物医学认证培训中心进行3年的职业培训。这还包括根据国际药物政策与实践学会/药物培训大纲完成药物医学学术研究生文凭（30个欧洲学分转换系统学分）以及为期1天的委员会考试。作为培训课程持续修订的一部分，我们正在根据国际药物政策与实践学会针对行业药物开发专家的能力框架，制定瑞士药物医学核心能力目录（SC-PM）。在本文中，我们讨论如何调整国际药物政策与实践学会能力框架的范围，以更好地反映其在瑞士学术机构或监管机构中的此类作用。
